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ABSTRACT
Title : Evaluation of subclinical neuropathy in type 1 diabetes mellitus
Background: Type 1 diabetes mellitus is caused by cell mediated autoimmune destruction of
?- cell in susceptible individuals along with some insulin resistance.About 60 to 70% of
people with diabetes have some form of neuropathy. This includes the central neuropathy
affecting the visual pathway and the peripheral neuropathy affecting the peripheral
nerves.Aim:To evaluate the subclinical central and peripheral neuropathy in type 1 Diabetes
mellitus patients.Objectives:(i)To evaluate the subclinical central neuropathy by visual
evoked potentials.(ii) To evaluate the subclinical peripheral neuropathy by sensory sural
nerve conduction study. (iii) To compare the findings between 3 groups of type 1 diabetic
patients with different disease duration. Materials and methods:Patients Diagnosed to have
type 1 DM with duration <5 years, 5-10 years and 10-15 years were included in the study,
each group with 20 cases. Age and sex matched controls were included in the study. VEP P100
latency and amplitude and sensory sural nerve conduction velocity and amplitude were
recorded. Results:The delays in P100 latencies were highly significant in 5-10 years and 11-15
years of diabetic groups and the reduction in mean amplitude values were highly significant
in 5-10 years and 11-15 years of diabetic groups when compared to controls. The decrease in
mean conduction velocity and amplitude of sural nerve was highly significant in 11-15 years
diabetic group when compared to control group.Conclusion: the changes in VEP and sensory
Sural  nerve  conduction   occur  in  type  1  diabetic  patients  much  before  the  development  of
overt or clinically apparent central neuropathy  and peripheral neuropathy and these changes
are related with the duration of disease.
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